Unknown

Dataset Information

Pneumococcal Conjugate Vaccine Impact on Serotype 3: A Review of Surveillance Data.


ABSTRACT:

Introduction

Limited changes in serotype 3 invasive pneumococcal disease (IPD) incidence rates after a decade of 13-valent pneumococcal conjugate vaccine (PCV13) introduction into several national immunization programs (NIP) have raised questions about PCV13's effectiveness against this serotype.

Methods

We analyzed the impact of pediatric PCV programs on serotype 3 IPD with two approaches. First, we reviewed the publicly available surveillance data from countries identified in two recently published reviews to describe the population impact of pediatric PCV13 or PCV10 vaccination programs on serotype 3 IPD. We then compared the observed trends in PCV10 and PCV13 countries to a previously described dynamic transmission model that simulates the spread of pneumococcal carriage

SUBMITTER: Sings HL 

PROVIDER: S-EPMC7954992 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature